Search Results - "Yeger, H"

Refine Results
  1. 1

    Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer by Islam, S.S., Mokhtari, R.B., Noman, A.S., Uddin, M., Rahman, M.Z., Azadi, M.A., Zlotta, A., van der Kwast, T., Yeger, H., Farhat, W.A.

    Published in Molecular carcinogenesis (01-05-2016)
    “…Activation of the sonic hedgehog (Shh) signaling pathway controls tumorigenesis in a variety of cancers. Here, we show a role for Shh signaling in the…”
    Get full text
    Journal Article
  2. 2

    Pulmonary neuroepithelial bodies are polymodal airway sensors: evidence for CO2/H+ sensing by Livermore, S, Zhou, Y, Pan, J, Yeger, H, Nurse, C A, Cutz, E

    “…Pulmonary neuroepithelial bodies (NEB) in mammalian lungs are thought to function as airway O2 sensors that release serotonin (5-HT) in response to hypoxia…”
    Get more information
    Journal Article
  3. 3
  4. 4

    Simultaneous Targeting of Bladder Tumor Growth, Survival, and Epithelial-to-Mesenchymal Transition with a Novel Therapeutic Combination of Acetazolamide (AZ) and Sulforaphane (SFN) by Islam, S S, Mokhtari, R B, Akbari, P, Hatina, J, Yeger, H, Farhat, W A

    Published in Targeted oncology (01-04-2016)
    “…Background Current chemotherapies for advanced stage metastatic bladder cancer often result in severe side effects, and most patients become drug resistant…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Cisplatin treatment increases survival and expansion of a highly tumorigenic side-population fraction by upregulating VEGF Flt1 autocrine signaling by Tsuchida, R, Das, B, Yeger, H, Koren, G, Shibuya, M, Thorner, P S, Baruchel, S, Malkin, D

    Published in Oncogene (26-06-2008)
    “…The cellular and molecular mechanisms of tumor progression following chemotherapy are largely unknown. Here, we demonstrate that cisplatin (CDDP) treatment…”
    Get full text
    Journal Article
  7. 7

    Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours by MARKS, A, SUTHERLAND, D. R, BAILEY, D, IGLESIAS, J, LAW, J, LEI, M, YEGER, H, BANERJEE, D, BAUMAL, R

    Published in British Journal of Cancer (01-05-1999)
    “…M2A antigen is an oncofetal antigen associated with germ cell neoplasia, present in testis on fetal gonocytes and re-expressed on carcinoma in situ (CIS) and…”
    Get full text
    Journal Article
  8. 8

    Gender differences in pulmonary regenerative response to naphthalene-induced bronchiolar epithelial cell injury by Oliver, J. R. , Kushwah, R. , Wu, J. , Cutz, E. , Yeger, H. , Waddell, T. K. , Hu, J. 

    Published in Cell proliferation (01-10-2009)
    “…Objectives:  Accumulating evidence suggests that gender affects the incidence and severity of several pulmonary diseases. Previous studies on mice have shown…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection by Jones, NL, Shannon, PT, Cutz, E, Yeger, H, Sherman, PM

    Published in The American journal of pathology (01-12-1997)
    “…Childhood acquisition of Helicobacter pylori is a critical risk factor for gastric cancer. Since tumorigenesis involves deregulation of proliferation and…”
    Get full text
    Journal Article
  11. 11

    In vitro cytoprotective activity of squalene on a bone marrow versus neuroblastoma model of cisplatin-induced toxicity : implications in cancer chemotherapy by Das, B, Yeger, H, Baruchel, H, Freedman, M.H, Koren, G, Baruchel, S

    Published in European journal of cancer (1990) (01-11-2003)
    “…The development of a non-toxic selective cytoprotective agent that preferentially protects normal tissues from chemotherapy toxicity, without protecting…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Proposal for a unified CCN nomenclature by Brigstock, D R, Goldschmeding, R, Katsube, K-i, Lam, S C-T, Lau, L F, Lyons, K, Naus, C, Perbal, B, Riser, B, Takigawa, M, Yeger, H

    Published in Molecular pathology (01-04-2003)
    “…A proposal is put forth to unify the nomenclature of the CCN family of secreted, cysteine rich regulatory proteins. In the order of their description in the…”
    Get full text
    Journal Article
  14. 14

    novH: differential expression in developing kidney and Wilm's tumors by Chevalier, G, Yeger, H, Martinerie, C, Laurent, M, Alami, J, Schofield, PN, Perbal, B

    Published in The American journal of pathology (01-06-1998)
    “…We previously established that the expression of the human nov gene (novH) was altered in Wilms' tumors and that levels of novH and WT1 mRNA were inversely…”
    Get full text
    Journal Article
  15. 15

    Report on the fifth international workshop on the CCN family of genes by Irvine, A. E., Perbal, B., Yeger, H.

    “…The Fifth International Workshop on the CCN Family of Genes was held in Toronto October 18–22, 2008. This bi-annual workshop provides a unique opportunity for…”
    Get full text
    Journal Article
  16. 16

    Fulminant hepatic failure in murine hepatitis virus strain 3 infection: tissue-specific expression of a novel fgl2 prothrombinase by Ding, J W, Ning, Q, Liu, M F, Lai, A, Leibowitz, J, Peltekian, K M, Cole, E H, Fung, L S, Holloway, C, Marsden, P A, Yeger, H, Phillips, M J, Levy, G A

    Published in Journal of Virology (01-12-1997)
    “…Erratum ( vol. 72 , p. 3504 ) Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Immunohistochemical detection of p53 in Wilms' tumors correlates with unfavorable outcome by Lahoti, C, Thorner, P, Malkin, D, Yeger, H

    Published in The American journal of pathology (01-05-1996)
    “…The role of p53 in the pathogenesis and progression of Wilms' tumors is only partly understood. Although p53 mutations were initially reported only in…”
    Get full text
    Journal Article
  20. 20

    MYCN protein expression as a predictor of neuroblastoma prognosis by CHAN, H. S. L, GALLIE, B. L, DEBOER, G, HADDAD, G, IKEGAKI, N, DIMITROULAKOS, J, YEGER, H, LING, V

    Published in Clinical cancer research (01-10-1997)
    “…About half of nonlocalized neuroblastomas have MYCN gene amplification and usually progress rapidly, but the half without such amplification also do poorly,…”
    Get full text
    Journal Article